NYSE American - Delayed Quote USD

China Pharma Holdings, Inc. (CPHI)

0.3023 -0.0237 (-7.27%)
At close: April 26 at 3:52 PM EDT
0.3192 +0.02 (+5.59%)
After hours: April 26 at 7:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
7,011.2990
7,011.2990
8,104.0920
9,641.9250
10,866.4490
Cost of Revenue
7,292.3840
7,292.3840
8,598.0080
9,292.6550
8,913.5430
Gross Profit
-281.0850
-281.0850
-493.9160
349.2700
1,952.9060
Operating Expense
2,486.4920
2,486.4920
3,148.9120
3,464.9950
4,416.0130
Operating Income
-2,767.5770
-2,767.5770
-3,642.8280
-3,115.7250
-2,463.1070
Net Non Operating Interest Income Expense
-326.9980
-326.9980
-423.8640
-538.9660
-288.4840
Other Income Expense
15.7570
15.7570
93.8510
255.2150
-115.1860
Pretax Income
-3,078.8180
-3,078.8180
-3,972.8410
-3,399.4760
-2,866.7770
Net Income Common Stockholders
-3,078.8180
-3,078.8180
-3,972.8410
-3,399.4760
-2,866.7770
Diluted NI Available to Com Stockholders
-3,078.8180
-3,078.8180
-3,972.8410
-3,399.4760
-2,866.7770
Basic EPS
-0.91
-0.91
-3.78
-3.70
-3.50
Diluted EPS
-0.91
-0.91
-3.78
-3.70
-3.50
Basic Average Shares
3,383.5730
3,383.5730
1,051.3710
922.5850
872.4650
Diluted Average Shares
3,383.5730
3,383.5730
1,051.3710
922.5850
872.4650
Total Operating Income as Reported
-2,751.8200
-2,751.8200
-3,548.9770
-2,860.5100
-2,578.2930
Total Expenses
9,778.8760
9,778.8760
11,746.9200
12,757.6500
13,329.5560
Net Income from Continuing & Discontinued Operation
-3,078.8180
-3,078.8180
-3,972.8410
-3,399.4760
-2,866.7770
Normalized Income
-3,094.5750
-3,094.5750
-4,066.6920
-3,654.6910
-2,751.5910
Interest Income
6.6020
6.6020
10.7550
3.0350
5.6750
Interest Expense
333.6000
333.6000
434.6190
542.0010
294.1590
Net Interest Income
-326.9980
-326.9980
-423.8640
-538.9660
-288.4840
EBIT
-2,745.2180
-2,745.2180
-3,538.2220
-2,857.4750
-2,572.6180
EBITDA
8.4350
8.4350
-837.6890
230.3450
106.8520
Reconciled Cost of Revenue
7,292.3840
7,292.3840
8,598.0080
9,292.6550
8,913.5430
Reconciled Depreciation
2,753.6530
2,753.6530
2,700.5330
3,087.8200
2,679.4700
Net Income from Continuing Operation Net Minority Interest
-3,078.8180
-3,078.8180
-3,972.8410
-3,399.4760
-2,866.7770
Total Unusual Items Excluding Goodwill
15.7570
15.7570
93.8510
255.2150
-115.1860
Total Unusual Items
15.7570
15.7570
93.8510
255.2150
-115.1860
Normalized EBITDA
-7.3220
-7.3220
-931.5400
-24.8700
222.0380
12/31/2020 - 4/17/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SXTC China SXT Pharmaceuticals, Inc.
1.0500
+1.94%
 
PTPI Petros Pharmaceuticals, Inc.
0.6399
0.00%
 
AKAN Akanda Corp.
0.1030
+12.57%
 
IMCC IM Cannabis Corp.
0.5548
-2.12%
 
SBFM Sunshine Biopharma, Inc.
0.9500
+17.66%
 
YCBD cbdMD, Inc.
0.8711
-3.21%
 
RGC Regencell Bioscience Holdings Limited
5.35
-5.31%
 
INQD Indoor Harvest Corp.
0.0005
0.00%
 
SNOA Sonoma Pharmaceuticals, Inc.
0.1590
-1.18%
 
QLI Qilian International Holding Group Limited
0.7486
-4.03%